Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Summary

The purpose of this study is to assess the safety and effectiveness of natural killer (NK) cell and natural killer T (NKT) cell-based autologous adoptive immunotherapy in subjects with metastatic, treatment-refractory breast cancer, glioma, hepatocellular carcinoma, squamous cell lung cancer, pancreatic cancer, colon cancer or prostate cancer.

Timeline

Start

2009-05

Primary completion

2010-06

Completion

—

Drugs

Indications